Watkins Thomas
Insider CIK 1307935 · VNDA Director · HZNP Director · HGSI Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 4,016 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 8,548 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 23,092 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 31,153 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 10,838 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer | 2023-10-06 | 2023-10-06 | 110,447 | $116.50 | $12.87M | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer | 2023-10-06 | 2023-10-06 | 55,953 | $116.50 | $6.52M | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer | 2023-10-06 | 2023-10-06 | 10,000 | $116.50 | $1.17M | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2023-09-29 | 2023-10-02 | 40,000 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2023-09-29 | 2023-10-02 | 20,000 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2023-09-29 | 2023-10-02 | 21,323 | — | $0 | 10,838 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2023-09-29 | 2023-10-02 | 20,000 | $15.96 | $319.2K | 89,124 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2023-09-29 | 2023-10-02 | 21,323 | $13.87 | $295.8K | 110,447 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2023-09-29 | 2023-10-02 | 40,000 | $12.29 | $491.6K | 69,124 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2023-07-27 | 2023-07-28 | 4,016 | — | $0 | 4,016 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2023-04-28 | 2023-05-02 | 3,913 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2023-04-28 | 2023-05-02 | 3,913 | — | $0 | 29,124 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2022-06-02 | 2022-06-03 | 15,000 | — | $0 | 0 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2022-06-02 | 2022-06-03 | 15,000 | $4.15 | $62.3K | 69,505 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2022-06-02 | 2022-06-03 | 6,441 | $9.90 | $63.8K | 63,064 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2022-04-29 | 2022-05-02 | 4,223 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2022-04-29 | 2022-05-02 | 4,223 | — | $0 | 75,164 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2022-04-28 | 2022-05-02 | 3,913 | — | $0 | 3,913 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2021-06-10 | 2021-06-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award | 2021-06-10 | 2021-06-14 | 5,000 | — | $0 | 54,505 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2021-04-30 | 2021-04-30 | 11,098 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2021-04-30 | 2021-04-30 | 11,098 | — | $0 | 70,941 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2021-04-29 | 2021-04-30 | 4,223 | — | $0 | 4,223 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2021-02-16 | 2021-02-18 | 15,000 | — | $0 | 0 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2021-02-16 | 2021-02-18 | 15,000 | $7.11 | $106.7K | 55,323 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2021-02-16 | 2021-02-18 | 5,818 | $18.54 | $107.9K | 49,505 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2020-06-11 | 2020-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award | 2020-06-11 | 2020-06-15 | 5,000 | — | $0 | 40,323 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2020-05-29 | 2020-06-02 | 15,000 | — | $0 | 0 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2020-05-29 | 2020-06-02 | 9,677 | $11.50 | $111.3K | 35,323 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2020-05-29 | 2020-06-02 | 15,000 | $7.38 | $110.7K | 45,000 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2020-05-02 | 2020-05-04 | 15,390 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2020-05-02 | 2020-05-04 | 15,390 | — | $0 | 59,843 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2020-04-30 | 2020-05-04 | 11,098 | — | $0 | 11,098 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2019-06-13 | 2019-06-17 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award | 2019-06-13 | 2019-06-17 | 5,000 | — | $0 | 30,000 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2019-05-03 | 2019-05-06 | 15,320 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2019-05-03 | 2019-05-06 | 4,132 | $26.54 | $109.7K | 44,453 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2019-05-03 | 2019-05-06 | 15,320 | — | $0 | 48,585 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2019-05-02 | 2019-05-06 | 15,390 | — | $0 | 15,390 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2018-06-13 | 2018-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award | 2018-06-13 | 2018-06-15 | 5,000 | — | $0 | 25,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2018-05-03 | 2018-05-04 | 15,000 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2018-05-03 | 2018-05-07 | 15,320 | — | $0 | 15,320 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2018-05-03 | 2018-05-07 | 32,161 | — | $0 | 32,161 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2018-05-03 | 2018-05-07 | 14,054 | — | $0 | 0 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2018-05-03 | 2018-05-04 | 15,000 | $4.98 | $74.7K | 20,000 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2018-05-03 | 2018-05-07 | 14,054 | — | $0 | 33,265 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2017-06-15 | 2017-06-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award | 2017-06-15 | 2017-06-19 | 5,000 | — | $0 | 5,000 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2017-05-03 | 2017-05-04 | 14,054 | — | $0 | 14,054 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2017-05-03 | 2017-05-04 | 31,153 | — | $0 | 31,153 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2017-05-03 | 2017-05-04 | 13,953 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2017-05-03 | 2017-05-04 | 13,953 | — | $0 | 19,211 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2016-06-16 | 2016-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2016-05-06 | 2016-05-10 | 5,258 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2016-05-06 | 2016-05-10 | 5,258 | — | $0 | 5,258 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2016-05-03 | 2016-05-05 | 23,092 | — | $0 | 23,092 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2016-05-03 | 2016-05-05 | 13,953 | — | $0 | 13,953 | SEC↗ |
| HZNP Horizon Pharma plc | P Buy | 2015-08-19 | 2015-08-21 | 10,000 | $31.32 | $313.2K | 10,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2015-06-18 | 2015-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2015-05-06 | 2015-05-08 | 5,258 | — | $0 | 5,258 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2015-05-06 | 2015-05-08 | 8,548 | — | $0 | 8,548 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer | 2014-09-19 | 2015-01-26 | 6,000 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | A Award | 2014-09-19 | 2015-01-26 | 6,000 | — | $0 | 6,000 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer deriv | 2014-09-19 | 2014-09-22 | 20,000 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer deriv | 2014-09-19 | 2014-09-22 | 40,000 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2014-09-19 | 2014-09-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2014-09-19 | 2014-09-22 | 40,000 | — | $0 | 40,000 | SEC↗ |
| HZNP Horizon Pharma plc | P Buy | 2014-08-14 | 2015-01-26 | 6,000 | $9.76 | $58.6K | 6,000 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | A Award deriv | 2014-06-27 | 2014-06-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2014-05-22 | 2014-05-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | A Award deriv | 2014-04-15 | 2014-04-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2014-03-14 | 2014-03-17 | 35,000 | — | $0 | 0 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2014-03-14 | 2014-03-17 | 35,000 | $9.40 | $329.0K | 35,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2014-03-14 | 2014-03-17 | 35,000 | $17.66 | $618.1K | 0 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2013-06-20 | 2013-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | D To issuer deriv | 2012-07-30 | 2012-08-01 | 1,250,000 | $14.25 | $17.81M | 0 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | D To issuer deriv | 2012-07-30 | 2012-08-01 | 325,000 | $14.25 | $4.63M | 0 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | D To issuer deriv | 2012-07-30 | 2012-08-01 | 360,000 | $14.25 | $5.13M | 0 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | D To issuer deriv | 2012-07-30 | 2012-08-01 | 500,000 | $14.25 | $7.13M | 0 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | D To issuer deriv | 2012-07-30 | 2012-08-01 | 500,000 | $14.25 | $7.13M | 0 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | D To issuer deriv | 2012-07-30 | 2012-08-01 | 400,000 | $14.25 | $5.70M | 0 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | U Tender | 2012-07-30 | 2012-08-17 | 10,469 | $14.25 | $149.2K | 0 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | G Gift | 2012-07-25 | 2012-08-01 | 166,075 | $14.25 | $2.37M | 0 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | G Gift | 2012-07-25 | 2012-08-17 | 167,000 | — | $0 | 10,469 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | P Buy | 2012-06-29 | 2012-08-17 | 3,364 | $6.32 | $21.3K | 177,469 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2012-06-14 | 2012-06-18 | 15,000 | — | $0 | 15,000 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | A Award deriv | 2012-03-10 | 2012-03-12 | 360,000 | — | $0 | 360,000 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | G Gift | 2011-11-07 | 2012-08-17 | 5,000 | — | $0 | 174,105 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | P Buy | 2011-06-30 | 2012-08-17 | 1,030 | $20.62 | $21.2K | 169,105 | SEC↗ |
| HGSI HUMAN GENOME SCIENCES INC | G Gift | 2010-11-02 | 2012-08-17 | 2,000 | — | $0 | 168,075 | SEC↗ |